Added to YB: 2026-09-15
Pitch date: 2026-09-11
SOFW.TA [bullish]
SofWave Medical Ltd.
-1.84%
current return
Author Info
No bio for this author
Company Info
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally.
Market Cap
ILS 394.8M
Pitch Price
ILS 33.10
Price Target
100.00 (+202%)
Dividend
N/A
EV/EBITDA
29.33
P/E
49.52
EV/Sales
3.43
Sector
Health Care Equipment and Supplies
Category
growth
Sofwave Medical: Lifting Skin While the Beauty Sector Sags
SOFW.TA: Sofwave pairs 43% Q2 revenue growth and five consecutive profitable quarters with 46% recurring usage-fee revenue, despite a weak aesthetic-device market. At ILS 34.12, the shares trade at roughly 15–16x estimated 2027 adjusted earnings; applying a 24x multiple to 2029 EPS implies about ILS 100 and a 44% annual return. The case depends on margin expansion and faces equipment cyclicality, competition and dilution.
Read full article (12 min)